News

Η Protavio είναι στην ευχάριστη θέση να ανακοινώσει ότι αποτελεί πλέον τον επίσημο αντιπρόσωπο της Olink Proteomics μέρος της Thermo Fisher Scientific σε Ελλάδα,...

Last week, Protavio was proud to support and participate in the 7th Advances in Circulating Tumor Cells meeting: “Liquid Biopsy: from Bench to Bedside”,...

On Tuesday, July 1st 2025, Protavio’s co‑founder and National Technical University of Athens professor, Dr. Leonidas Alexopoulos, spoke at the 2nd Synergies Forum on...

Protavio took part in the European Association for Cancer Research Annual Congress (EACR 2025), held 16–19 June in Lisbon, Portugal, where leading scientists gathered...

Protavio is proud to announce the launch of Project SHIELD, a four-year Horizon Europe-funded collaboration that unites more than 25 research centres, clinical sites,...

Protavio concluded an active participation at the IFCC-EFLM EuroMedLab Brussels 2025 congress, held from 18 to 22 May at Brussels, Belgium. Gathering thousands of...

Protavio is proud to announce its official certification as service provider for the newly launched Olink Reveal platform from Olink Proteomics. This certification marks...

Protavio is proud to announce its active participation at the 5th Consortium Meeting of the DIOPTRA Project, held on April 8-9, 2025 in the...

March is Colorectal Cancer (CRC) Awareness Month, a time dedicated to highlighting the importance of early detection and prevention in combating one of the...

In September 2024, Protavio proudly announced its official certification as an Olink Service Provider by Olink Proteomics, underscoring the company’s dedication to advancing proteomic...

Protavio’s co-founder and National Technical University of Athens Professor, Dr. Leonidas Alexopoulos, took part in the recently concluded 9th Annual Conference of the Hellenic...

Olink Reveal is the newest solution in high-throughput proteomics, leveraging Olink’s well-established Proximity Extension Assay (PEA) technology combined with next-generation sequencing (NGS) readouts. Similar...

Last month, the College of Engineering at Koç University hosted a seminar featuring our co-founder and Professor at the National Technical University of Athens...

We are proud to announce that Protavio has successfully passed a scheduled Good Manufacturing Practice (GMP) audit conducted by one of our major pharmaceutical...

In the rapidly evolving diagnostics landscape, the In Vitro Diagnostic Regulation (IVDR) sets the benchmark for in vitro diagnostic devices within the European market....

It was a pleasure for Protavio to participate in xMAP® Connect 2024, held in Amsterdam on November 12-13. As a trusted partner in the...

Protavio is pleased to share our active participation in the 4th consortium meeting of the DIOPTRA project, held in Riga, Latvia, on October 29th...

Protavio is delighted to announce our successful participation in the World Vaccine Congress EU 2024, which took place from October 29th to 31st in...

Protavio is excited to share the highlights of our impactful presence at the HUPO 2024 World Congress, held from October 20th to 24th in...

Last week, Protavio had the privilege of attending the Olink User Group Meeting 2024, held in Barcelona, where Olink experts gathered to share insights...

Protavio recently had the opportunity to present at the Olink Proteomics World virtual conference on September 26th, where we unveiled our cutting-edge work in...

Protavio is pleased to announce our participation in the 8th Network Meeting for Users of Multiplex Immune Assays held in Copenhagen, Denmark. Our co-founder,...

It was a great honor to have the story of Protavio presented at the Rectors’ Meeting held at the University of Patras in July....

Last week, the 1st Greek Forum on Cancer, organized by the Hellenic Cancer Federation | ELLOK, provided a holistic view of our battle with...

Protavio is thrilled to be participating as an exhibitor at the EPHAR2024 conference organized by The Federation of European Pharmacological Societies in Athens, Greece!...

Protavio has finished the latest GMP production of the custom Luminex serological assays for vaccine assessment and Quality Control (QC). These Luminex® Serological Assays...

We’re excited to announce the latest addition to the Protavio family of xMAP instruments: the Luminex xMAP INTELLIFLEX DR-SE System. With this acquisition, our...

We are excited to announce the successful completion of our latest GMP production for the 13-Plex Pneumococcal IgG Serological Luminex Assay. This latest milestone...

Protavio Ltd is thrilled to announce the winner of our highly anticipated Olink Proteomics Sample Testing Contest. This unique contest was designed to celebrate...

Protavio is proud to announce its successful participation as a sponsor at the prestigious Biomarkers UK event, held in London this February. The event,...

Olink Explore sample testing contest! Apply to win a complimentary Olink® Explore testing service....